Summary & Overview
CPT 92002: Intermediate Ophthalmological Exam for New Patients
CPT code 92002 is a nationally recognized billing code for intermediate ophthalmological services provided to new patients. This code is used by ophthalmologists, optometrists, and glaucoma specialists to document and bill for medical examinations and evaluations that initiate diagnostic and treatment programs. The service is most commonly delivered in an office setting, reflecting routine eye care for individuals presenting with new visual or ocular symptoms.
Major payers covering this code include Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare. Understanding coverage and reimbursement policies for 92002 is essential for providers and administrators seeking to optimize billing practices and ensure compliance with payer requirements.
Readers will gain insight into the clinical context of 92002, including its role in the spectrum of ophthalmological services, typical diagnoses associated with its use, and related codes for comprehensive and established patient visits. The publication also addresses common billing modifiers and taxonomy classifications relevant to this service. Policy updates and benchmarks are discussed to provide a comprehensive overview of how 92002 fits into current medical billing and reimbursement frameworks.
CPT Code Overview
CPT code 92002 represents ophthalmological services involving a medical examination and evaluation of a new patient, with the initiation of a diagnostic and treatment program. This intermediate-level service is typically performed in an office setting (Place of Service 11). The code is used by eye care professionals to assess new patients presenting with visual or ocular concerns, providing a structured approach to diagnosis and management.
Clinical & Coding Specifications
Clinical Context
A new patient presents to an ophthalmology office for evaluation of visual symptoms such as blurry vision, difficulty focusing, or possible glaucoma. The provider conducts a medical examination and evaluation, including history, assessment of visual function, and ocular health. Based on findings, the provider initiates a diagnostic and treatment plan, which may include prescribing corrective lenses, ordering further tests, or starting therapy for conditions like glaucoma. This workflow aligns with the use of CPT code 92002 for intermediate ophthalmological services for a new patient.
Coding Specifications
-
Modifiers:
- Modifier
25: Used when a significant, separately identifiable evaluation and management service is performed by the same physician on the same day as another procedure or service. - Modifier
57: Used when the evaluation and management service results in the decision for surgery.
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
207W00000X | Ophthalmology |
152W00000X | Optometrist |
207WX0009X | Glaucoma Specialist |
These taxonomies represent providers who commonly perform ophthalmological evaluations and initiate treatment programs.
Related Diagnoses
-
H52.4- Presbyopia- Relevant for patients experiencing age-related difficulty focusing on near objects, often prompting an ophthalmological evaluation.
-
H53.9- Unspecified visual disturbance- Used when a patient presents with visual symptoms that are not yet clearly defined, warranting an intermediate evaluation.
-
H40.9- Unspecified glaucoma- Indicates suspicion or diagnosis of glaucoma, which may require initiation of a treatment program during the visit.
-
H54.7- Unspecified visual loss- Applied when a patient reports vision loss without a specific cause identified, necessitating further assessment.
-
Z01.00- Encounter for examination of eyes and vision without abnormal findings- Used for routine eye examinations where no abnormalities are found, but a medical evaluation is still performed.
Related CPT Codes
-
92004: Ophthalmological services: comprehensive, new patient- Used for a more extensive examination and evaluation for new patients. May be selected instead of
92002if the clinical situation requires a comprehensive assessment.
- Used for a more extensive examination and evaluation for new patients. May be selected instead of
-
92012: Ophthalmological services: intermediate, established patient- Used for intermediate evaluation and management for established patients. Often follows an initial visit coded as
92002.
- Used for intermediate evaluation and management for established patients. Often follows an initial visit coded as
-
92014: Ophthalmological services: comprehensive, established patient- Used for comprehensive evaluation and management for established patients. May be used in follow-up visits requiring a thorough assessment.
-
92133: Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; optic nerve- Used for diagnostic imaging of the optic nerve. May be performed in conjunction with
92002when further evaluation is needed.
- Used for diagnostic imaging of the optic nerve. May be performed in conjunction with
-
92134: Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina- Used for diagnostic imaging of the retina. May be performed alongside
92002for patients with retinal concerns.
- Used for diagnostic imaging of the retina. May be performed alongside
Codes 92133 and 92134 are commonly used together with 92002 when additional diagnostic imaging is required. Codes 92004, 92012, and 92014 are alternatives based on patient status and exam comprehensiveness.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT code 92002 is $88.18, while the BUCA (average commercial) mean rate is $83.88. Among the commercial payers, UnitedHealth Group and Cigna have the highest mean rates at $106.81 and $103.67, respectively, with Aetna and Blue Cross Blue Shield at the lower end.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Medicare shows the tightest range at $9.00, indicating relatively consistent reimbursement. In contrast, Cigna and UnitedHealth Group exhibit the widest ranges, at $60.00 and $56.67 respectively, reflecting greater variability in commercial rates. Aetna and Blue Cross Blue Shield have moderate dispersion, with ranges of $37.00 and $30.67.
The table and chart below present the full breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.